title: USEFULNESS OF EVALUATION OF ANTIMEASLES ANTIBODIES IN PRETERM BABIES.
abstract: As per WHO recommendations, measles vaccine is administered at the age of 9 months which is based on studies demonstrating seroconversion (from positive to negative) at this age. However this contention may not hold good in preterm babies since they may have lower initial levels of passively transferred IgG antimeasles antibodies of maternal origin. To explore this possibility, 50 preterm babies (gestational age less than 37 weeks) were studied for antimeasles antibodies. Serum samples were collected at birth and then at 3 months and 5 months of age in all the cases. Antimeasles antibody assay was done in all the serum samples using ELISA kits. At birth 32% of infants were positive for antimeasles antibodies whereas 60% were weakly positive and 8% were negative. At 3 months of age 50% were sero negative, 2% positive and 40% weakly positive. The sero negativity was found to be 98% at 5 months with only 2% remaining positive. Since seroconversion is seen to occur in this vast majority of preterm infants at the age of 5 months, antimeasles vaccine should be administered at this age to this subset of more vulnerable babies.
authors.affiliation: Classified Specialist (Pathology and Immunology), Command Hospital(Eastern Command), Calcutta-27.
authors.forename: G S
authors.initials: GS
authors.lastname: Chopra
authors.affiliation: Commandant, Military Hospital, Meerut.
authors.forename: P K
authors.initials: PK
authors.lastname: Sarkar
authors.affiliation: PG Trainee Paediatrics.
authors.forename: A
authors.initials: A
authors.lastname: Dhulia
keywords: Antimeasles antibodies; Preterm babies; Seroconversion